The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure. [PDF]
Liebchen U +5 more
europepmc +1 more source
International audienceBackground: Patients with acute coronary syndrome requiring coronary artery bypass graft surgery while on ticagrelor face a high risk of perioperative bleeding because of its strong antiplatelet effect.
Mauduit, Nicolas +10 more
core +1 more source
Mortality and adverse events of hemoadsorption with CytoSorb® in critically ill patients: A systematic review and meta-analysis of randomized controlled trials. [PDF]
Heymann M, Schorer R, Putzu A.
europepmc +1 more source
The International, Prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: Interim Results in Patients with Septic Shock. [PDF]
Ferrer R +24 more
europepmc +1 more source
Hemoperfusion with CytoSorb® in Critically Ill COVID-19 Patients. [PDF]
Peng JY +5 more
europepmc +1 more source
The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients. [PDF]
Ferrer R +28 more
europepmc +1 more source
Extracorporeal Blood Purification with CytoSorb® Hemoadsorption in Valve Surgery for Infective Endocarditis: A Case Series. [PDF]
Jonjev ŽS +4 more
europepmc +1 more source
Hemoadsorption Using CytoSorb® in Patients with Infective Endocarditis: A German-Based Budget Impact Analysis. [PDF]
Rao C +7 more
europepmc +1 more source
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure
CytoSorb is a hemoadsorptive column used to remove high concentrations of proinflammatory cytokines in septic shock. Data on CytoSorb application in acute-on-chronic liver failure (ACLF) is lacking. This retrospective observational study analyzed 21 ACLF
Lorenz Balcar +8 more
core +1 more source

